Clinical Trials Browser

Phase 2 × avasopasem manganese × Clear all

NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Phase 2 Terminated

39 enrolled 12 charts

Esophagitis

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Phase 2 Completed

38 enrolled 10 charts

Head and Neck Neoplasms, Stomatitis